共 11 条
Comparison of Lymphedema in Patients With Axillary Lymph Node Dissections to Those With Sentinel Lymph Node Biopsy Followed by Immediate and Delayed ALND
被引:14
作者:
Kuwajerwala, Nafisa Kayam
[1
,2
]
Feczko, Claire
Dekhne, Nayana
[1
,2
]
Pettinga, Jane
[1
,2
]
Lucia, Victoria C.
[3
]
Riutta, Justin
Vicini, Frank
[4
]
机构:
[1] William Beaumont Hosp, Dept Surg, Troy, NY USA
[2] William Beaumont Hosp, Dept Surg, Royal Oak, MI 48072 USA
[3] William Beaumont Hosp, Res Inst, Royal Oak, MI USA
[4] William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI 48072 USA
来源:
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
|
2013年
/
36卷
/
01期
关键词:
lymphedema;
immediate ALND;
delayed ALND;
SLNB;
BREAST-CANCER;
COOPERATIVE GROUP;
TRIAL;
MORBIDITY;
D O I:
10.1097/COC.0b013e31823a4956
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Purpose: The purpose of the study was to show that delayed axillary lymph node dissection (ALND) has higher rates of lymphedema compared with immediate ALND, using data from NSABP-B32 at Beaumont Hospital. Method: NSABP B-32 at Beaumont had 207 patients with follow-up data on 199 patients, randomizing clinically negative axilla to sentinel lymph node biopsy (SLNB)+ALND (GrA N = 98), and SLNB+cytology +/- ALND (GrB N = 101). All patients had preoperative volumetric arm measurements and only node negatives had routine postoperative measurements assessing lymphedema for 36 months. We contacted node-positive patients for postoperative measurements for this study. Twenty-four and 15 cytology-positive patients had SLNB+ALND in GrA and GrB, respectively (SubGrA1 N = 24; SubGrB1 N = 15). Fourteen hematoxylin and eosin-positive patients had delayed ALND (SubGrB2a N = 14). Results: Lymphedema rate for node-positive SLNB+ALND was 10.3% [SubGrA1 (3/24)+SubGrB1 (1/15) = 4/39] and node-negative SLNB+ALND was 6.8% (SubGrA2 = 5/74). Lymphedema was 14.3% for delayed ALND in SubGrB2a (2 of 14) and 0% for 72 SLNBs in SubGrB2b. Our study comparing immediate and delayed ALND lymphedema was not statistically significant (10.3% vs. 14.3%, P = 0.65). Comparing node-negative ALND (SubGrA2 = 5/74 = 6.8%) to node-positive ALND (A1+B1+B2a = 6/53 = 11.3%) was not statistically significant (P = 0.52). Comparing lymphedema for node-negative ALND (SubGrA2) to SLNB (SubGrB2b) only approached significance (6.8% vs. 0%, P = 0.058). Conclusions: The rate of lymphedema was higher in delayed ALND but not statistically significant. Comparison, however, is difficult, given the limited sample size. We urge the other centers of NSABP-B32 to validate this, by contacting the node-positive patients for measurements. The lymphedema rate for SLNB alone was 0% and approached statistical significance when compared with node-negative ALND.
引用
收藏
页码:20 / 23
页数:4
相关论文